
|Podcasts|September 16, 2021
Episode 91: A New Way to Partner With Academia
Author(s)Elaine Quilici, Miranda Schmalfuhs
Advertisement
Dr. Michael Henderson, Chief Business Officer of BridgeBio Pharma, talks about how his company is partnering with academia in a novel way to develop important programs that might otherwise be dropped.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
3
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
4
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
5

